应用酶联雌二醇免疫组化方法检测卵巢上皮性癌雌激素受体(ER)20例,阳性16例,阳性率80％。宫内膜癌21例,阳性15例,阳性率71％,二组材料显示肿瘤的分化越好,ER水平越高。ER阳性者应用他莫西芬(Tamoxifen)联合化疗,随访结果ER阳性者较ER阴性者生存时间长,ER阴性者术后复发早,死亡率高。 Enzyme-linked estradiol immunohistochemistry was used to detect 20 estrogen receptor (ER) in ovarian epithelial carcinoma, 16 were positive, the positive rate was 80%. Endometrial cancer in 21 cases, 15 were positive, the positive rate of 71%, the two groups of materials showed that the better the tumor differentiation, the higher the level of ER. ER-positive patients were treated with Tamoxifen combined with chemotherapy. The follow-up results showed that ER-positive patients had longer survival time than ER-negative patients, and ER-negative patients had early postoperative recurrence and high mortality rate.